Stock listing

Cyclopharm Limited

Selected listing: CYCMF · OTC · USD · US

Cyclopharm Limited (OTC:CYCMF), Health Technology. Latest release Aug 23, 2026: CYC 1H2026 Results Summary.

CYCMF:OTCUSDUSUpdated October 2, 2026
Cyclopharm Limited logo
Ticker
OTC:CYCMF
Asset type
Stock
Sector
Health Technology
Industry
Medical Specialties
Exchange
OTC
Currency
USD

About Cyclopharm Limited

The company specializes in the development and commercialization of innovative medical imaging technologies. Cyclopharm focuses on enhancing patient care through its advanced solutions in the nuclear medicine sector.

Latest news from Cyclopharm Limited

CYC 1H2026 Results Summary

August 23, 2026

New US Lung Imaging Guidelines Name Technegas as Preferred A

July 28, 2026

Immediate 11-Site Technegas Rollout at University Hospitals

July 14, 2026

CYC First-Half 2026 Update

July 1, 2026

USA Technegas Expansion Update

March 30, 2026

All Cyclopharm Limited news →

Research Cyclopharm Limited

Cyclopharm Limited company profile

View the public company page for Cyclopharm Limited on 6ix.

Cyclopharm Limited news

Read company news and market updates connected to Cyclopharm Limited.

Cyclopharm Limited investor events

Find investor webinars, events, and replay context for Cyclopharm Limited.

Alternate listings

CYC:ASX

AU · AUD

Alternate listing for Cyclopharm Limited; the primary context on this page is CYCMF:OTC.